Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
478.87x
As of Aug 11, 2023
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Aug 11, 2023 | 478.87x |
| Aug 10, 2023 | 351.49x |
| Jun 5, 2023 | 510.79x |
| May 8, 2023 | 478.87x |
| May 5, 2023 | 478.87x |
| May 4, 2023 | 478.87x |
| May 2, 2023 | 478.87x |
| Mar 28, 2023 | 474.08x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison